Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-Health Disparities Subcommittee (HDS), 19186 [2016-07527]

Download as PDF 19186 Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 8:30 a.m.–4:30 p.m., EDT, April 28, 2016. Place: CDC, Building 19, Rooms 256/ 257, 1600 Clifton Road NE., Atlanta, Georgia 30329. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. The public is welcome to participate during the public comment period, which is tentatively scheduled from 4:00 p.m. to 4:15 p.m. This meeting is also available by teleconference. Please dial (866) 763– 0273 and enter code 6158968. Purpose: The Subcommittee will contribute to the ACD’s advice to the CDC Director on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. Matters for Discussion: The Health Disparities Subcommittee members will discuss progress toward the Subcommittee’s input to the ACD on disparity issues related to environmental health. The agenda is subject to change as priorities dictate. Web links: Windows Media: https:// wm.onlinevideoservice.com/CDC1. Flash: https:// www.onlinevideoservice.com/clients/ CDC/?mount=CDC3. Smart Phones and Mobile devices: https:// wowza01.sea.onlinevideoservice.com/ live/CDC3/playlist.m3u8. If you are unable to connect using the link, copy and paste the link into your web browser. Number for Technical Support: 404– 639–3737. Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE., M/S K–77, Atlanta, Georgia 30329 Telephone (770) 488– 8343, Email: LEL1@cdc.gov. VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–07527 Filed 4–1–16; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), RFA–CE–16–003, Research on Prescription Opioid Use, Opioid Prescribing, and Associated Heroin Risk. Time and Date: 8:30 a.m.–5:00 p.m., EDT, April 27–28, 2016 (Closed). Place: Atlanta Marriott Century Center, 2000 Century Blvd. NE., Atlanta, Georgia 30345. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research on Prescription Opioid Use, Opioid Prescribing, and Associated Heroin Risk’’, FOA RFA–CE–16–003. Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee Frm 00075 Fmt 4703 Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–07626 Filed 4–1–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sfmt 4703 Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 10:30 a.m.–5:00 p.m., EDT, April 28, 2016. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1–866–659– 0537 and the pass code is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Page 19186]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07527]



[[Page 19186]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--Health Disparities Subcommittee (HDS)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:
    Time and Date: 8:30 a.m.-4:30 p.m., EDT, April 28, 2016.
    Place: CDC, Building 19, Rooms 256/257, 1600 Clifton Road NE., 
Atlanta, Georgia 30329.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 50 people. The public is 
welcome to participate during the public comment period, which is 
tentatively scheduled from 4:00 p.m. to 4:15 p.m. This meeting is also 
available by teleconference. Please dial (866) 763-0273 and enter code 
6158968.
    Purpose: The Subcommittee will contribute to the ACD's advice to 
the CDC Director on strategic and other health disparities and health 
equity issues and provide guidance on opportunities for CDC.
    Matters for Discussion: The Health Disparities Subcommittee members 
will discuss progress toward the Subcommittee's input to the ACD on 
disparity issues related to environmental health.
    The agenda is subject to change as priorities dictate.
    Web links:
    Windows Media: https://wm.onlinevideoservice.com/CDC1.
    Flash: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
    Smart Phones and Mobile devices: https://wowza01.sea.onlinevideoservice.com/live/CDC3/playlist.m3u8.
    If you are unable to connect using the link, copy and paste the 
link into your web browser.
    Number for Technical Support: 404-639-3737.
    Contact Person for More Information: Leandris Liburd, Ph.D., 
M.P.H., M.A., Designated Federal Officer, Health Disparities 
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE., M/S K-77, Atlanta, Georgia 30329 Telephone (770) 488-8343, 
Email: LEL1@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-07527 Filed 4-1-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.